NCKSAP: Cardiac Amyloidosis, 1st Edition

Course Overview

This is a self-assessment CME activity in online format consisting of 30 multiple-choice questions. Each question includes an answer rationale and references for further studying. This module will be updated every 3 years. It is designed for practitioners who are performing nuclear imaging studies and want to increase their competence for certification, recertification or general practice improvement.

Target Audience

This activity is designed for nuclear cardiology physicians.

Learner Objectives

Upon completion of this module, the learner will be able to:

Describe cardiac amyloidosis subtypes and identify symptoms, associated clinical conditions, and typical non-nuclear imaging features.
Identify appropriate clinical scenarios for the use of Tc99m-PYP/DPD/HMDP imaging in cardiac amyloidosis.
Apply appropriate Tc99m-PYP/DPD/HMDP, I123-MIBG, and SPECT/PET amyloid binding tracer standardized imaging techniques to optimize assessment of cardiac amyloidosis.
Interpret and communicate diagnostic and prognostic findings on Tc99m-PYP/DPD/HMDP, I123-MIBG, and SPECT/PET amyloid binding tracers in the assessment of cardiac amyloidosis.

Overall Goal

The overall goal of this activity is to provide a comprehensive review of nuclear cardiology imaging procedures and best practices and increase physicians’ competence and performance in their ability to improve cardiovascular disease outcomes.

Continuing Education Term of Approval

Release Date: March 1, 2023
Expiration Date: February 28, 2026

Summary


Availability:	On-Demand
	Expires on Feb 28, 2026


Cost:	Physician & Scientist: $135.00 International Emerging Markets: $55.00 International Physician & Scientist: $135.00 Trainee: $55.00 Non-Physician (Member): $55.00 Physician (Non-Member): $225.00 Non-Physician (Non-Member): $225.00


Credit Offered:	10 CME Credits 10 MOC Points 10 COP Credits